BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND CDH1, uvomorulin, 999, P12830, ENSG00000039068, CDHE, Arc-1, UVO, LCAM, CD324, ECAD AND Prognosis
28 results:

  • 1. The genomic and immune landscapes of gastric cancer and their correlations with HER2 amplification and PD-L1 expression.
    Jing X; Luo Z; Wu J; Ye F; Li J; Song Z; Zhang Y; Shi M; Sun H; Fang Y; Jiang Y; Ji X
    Cancer Med; 2023 Dec; 12(24):21905-21919. PubMed ID: 38050871
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Prognostic Value of Serum α-Fetoprotein Level as an Important Characteristic of Tumor Biology for Patients Undergoing Liver Resection of Early-Stage Hepatocellular Carcinoma (BCLC Stage 0/A): A Large Multicenter Analysis.
    Yao LQ; Fan ZQ; Wang MD; Diao YK; Chen TH; Zeng YY; Chen Z; Wang XM; Zhou YH; Li J; Fan XP; Liang YJ; Li C; Shen F; Lv GY; Yang T
    Ann Surg Oncol; 2024 Feb; 31(2):1219-1231. PubMed ID: 37925654
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Clinical and Genomic Characterization of pancreatic Ductal Adenocarcinoma with Signet-Ring/Poorly Cohesive Cells.
    Simbolo M; Silvestris N; Malleo G; Mafficini A; Maggino L; Cocomazzi A; Veghini L; Mombello A; Pezzini F; Sereni E; Martelli FM; Gkountakos A; Ciaparrone C; Piredda ML; Ingravallo G; Paolino G; Nappo F; Rapposelli IG; Frassinetti L; Saragoni L; Lonardi S; Pea A; Paiella S; Fassan M; Brunetti O; Cingarlini S; Salvia R; Milella M; Corbo V; Lawlor RT; Scarpa A; Luchini C
    Mod Pathol; 2023 Sep; 36(9):100251. PubMed ID: 37355152
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Dual epigenetic changes in diabetes mellitus-associated pancreatic ductal adenocarcinoma correlate with downregulation of E-cadherin and worsened prognosis.
    Hara Y; Mizukami H; Yamazaki K; Yamada T; Igawa A; Takeuchi Y; Sasaki T; Kushibiki H; Murakami K; Kudoh K; Ishido K; Hakamada K
    J Pathol Clin Res; 2023 Sep; 9(5):354-366. PubMed ID: 37246239
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Comprehensive transcriptomic profiling and mutational landscape of primary gastric linitis plastica.
    Liu Z; Hong LL; Zheng JS; Ling ZN; Zhang ZL; Qi YN; Zhang XY; Zhu TY; Wang JL; Han J; Chen XL; Yu QM; Wang S; Li P; Ling ZQ
    Gastric Cancer; 2023 Mar; 26(2):203-219. PubMed ID: 36450891
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Bioinformatics Analysis of Differentially Expressed Genes and Related Pathways in Acute Pancreatitis.
    Zhong R; Luo X; Xu J; Jiang X; Yan Y; Shi X; Peng Y; Tang X; Fu X
    Pancreas; 2022 Aug; 51(7):821-829. PubMed ID: 36395409
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. MACC1 promotes pancreatic cancer metastasis by interacting with the EMT regulator SNAI1.
    Zhang X; Luo Y; Cen Y; Qiu X; Li J; Jie M; Yang S; Qin S
    Cell Death Dis; 2022 Nov; 13(11):923. PubMed ID: 36333284
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Management of Pathogenic cdh1 Variant Carriers Within the FREGAT Network: A Multicentric Retrospective Study.
    Bres C; Voron T; Benhaim L; Bergeat D; Parc Y; Karoui M; Genser L; Péré G; Demma JA; Bacoeur-Ouzillou O; Lebreton G; Thereaux J; Gronnier C; Dartigues P; Svrcek M; Bouzillé G; Bardier A; Brunac AC; Roche B; Darcha C; Bazille C; Doucet L; Belleannee G; Lejeune S; Buisine MP; Renaud F; Nuytens F; Benusiglio PR; Veziant J; Eveno C; Piessen G
    Ann Surg; 2022 Nov; 276(5):830-837. PubMed ID: 35856494
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. A prognostic information system for real-time personalized care: Lessons for embedded researchers.
    Lieu TA; Herrinton LJ; Needham T; Ford M; Liu L; Lyons D; Macapinlac J; Neugebauer R; Ng D; Prausnitz S; Robertson W; Schultz K; Stewart K; Van Den Eeden SK; Baer DM
    Healthc (Amst); 2021 Jun; 8 Suppl 1():100486. PubMed ID: 34175099
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. EIF3B promotes cancer progression in pancreatic cancer.
    Zhu H; Shan Y; Ge K; Lu J; Kong W; Jia C
    Scand J Gastroenterol; 2021 Mar; 56(3):281-288. PubMed ID: 33459066
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Metastatic renal cell carcinoma to the pancreas: Clinical features and treatment outcome.
    Shin TJ; Song C; Jeong CW; Kwak C; Seo S; Kang M; Chung J; Hong SH; Hwang EC; Park JY; Lee H
    J Surg Oncol; 2021 Jan; 123(1):204-213. PubMed ID: 33047324
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. miR-597-5p inhibits cell growth and promotes cell apoptosis by targeting ELK1 in pancreatic cancer.
    Li S; Li X; Xing X; Wang L
    Hum Cell; 2020 Oct; 33(4):1165-1175. PubMed ID: 32613573
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. FAM172A inhibits EMT in pancreatic cancer via ERK-MAPK signaling.
    Chen Y; Liu P; Shen D; Liu H; Xu L; Wang J; Shen D; Sun H; Wu H
    Biol Open; 2020 Feb; 9(2):. PubMed ID: 31988090
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Identification of Acute Pancreatitis-Related Genes and Pathways by Integrated Bioinformatics Analysis.
    Fan L; Hui X; Mao Y; Zhou J
    Dig Dis Sci; 2020 Jun; 65(6):1720-1732. PubMed ID: 31724100
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Loss of pancreatic E-Cadherin Causes Pancreatitis-Like Changes and Contributes to Carcinogenesis.
    Kaneta Y; Sato T; Hikiba Y; Sugimori M; Sue S; Kaneko H; Irie K; Sasaki T; Kondo M; Chuma M; Shibata W; Maeda S
    Cell Mol Gastroenterol Hepatol; 2020; 9(1):105-119. PubMed ID: 31526907
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Worsened outcome in patients with pancreatic ductal carcinoma on long-term diabetes: association with E-cadherin1 (cdh1) promoter methylation.
    Saito T; Mizukami H; Umetsu S; Uchida C; Inaba W; Abe M; Takahashi K; Kudo K; Itabashi C; Yagihashi S; Hakamada K
    Sci Rep; 2017 Dec; 7(1):18056. PubMed ID: 29273724
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Calreticulin promotes EGF-induced EMT in pancreatic cancer cells via Integrin/EGFR-ERK/MAPK signaling pathway.
    Sheng W; Chen C; Dong M; Wang G; Zhou J; Song H; Li Y; Zhang J; Ding S
    Cell Death Dis; 2017 Oct; 8(10):e3147. PubMed ID: 29072694
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Targeting the PD-L1/DNMT1 axis in acquired resistance to sorafenib in human hepatocellular carcinoma.
    Liu J; Liu Y; Meng L; Liu K; Ji B
    Oncol Rep; 2017 Aug; 38(2):899-907. PubMed ID: 28627705
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Impact of postoperative glycemic control and nutritional status on clinical outcomes after total pancreatectomy.
    Shi HJ; Jin C; Fu DL
    World J Gastroenterol; 2017 Jan; 23(2):265-274. PubMed ID: 28127200
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Aberrant expression of nuclear HDAC3 and cytoplasmic cdh1 predict a poor prognosis for patients with pancreatic cancer.
    Jiao F; Hu H; Han T; Zhuo M; Yuan C; Yang H; Wang L; Wang L
    Oncotarget; 2016 Mar; 7(13):16505-16. PubMed ID: 26918727
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.